Joel H. Kaufman - Net Worth and Insider Trading

Joel H. Kaufman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joel H. Kaufman owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .

Click here to see the complete history of Joel H. Kaufman’s form 4 insider trades.

Insider Ownership Summary of Joel H. Kaufman

Ticker Comapny Transaction Date Type of Owner
NAVB Navidea Biopharmaceuticals Inc 2020-11-04 Chief Business Officer

Joel H. Kaufman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joel H. Kaufman Ownership Network

Ownership Network List of Joel H. Kaufman

No Data

Ownership Network Relation of Joel H. Kaufman


Joel H. Kaufman Owned Company Details

What does Navidea Biopharmaceuticals Inc do?

Who are the key executives at Navidea Biopharmaceuticals Inc?

Joel H. Kaufman is the Chief Business Officer of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .

Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Navidea Biopharmaceuticals Inc Insider Transactions

No Available Data

Joel H. Kaufman Mailing Address

Above is the net worth, insider trading, and ownership report for Joel H. Kaufman. You might contact Joel H. Kaufman via mailing address: 4995 Bradenton Ave, Suite 240, Dublin Oh 43017.

Discussions on Joel H. Kaufman

No discussions yet.